Cover Image
市場調查報告書

行動醫療的全球市場 (設備,服務,應用,相關利益者,各地區) - 產業分析,市場規模,佔有率,趨勢,企業簡介,需求,考察,機會及預測:2014-2020年

Global mHealth Market (Devices, Services, Application, Stakeholders and Geography) - Industry Analysis, Market Size, Share, Growth, Company Profiles, Demand, Insights, Opportunities, Trends and Forecast, 2014 - 2020

出版商 Allied Market Research 商品編碼 332536
出版日期 內容資訊 英文 165 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
行動醫療的全球市場 (設備,服務,應用,相關利益者,各地區) - 產業分析,市場規模,佔有率,趨勢,企業簡介,需求,考察,機會及預測:2014-2020年 Global mHealth Market (Devices, Services, Application, Stakeholders and Geography) - Industry Analysis, Market Size, Share, Growth, Company Profiles, Demand, Insights, Opportunities, Trends and Forecast, 2014 - 2020
出版日期: 2015年05月01日 內容資訊: 英文 165 Pages
簡介

行動醫療 (mHealth)是針對受嚴重慢性疾病所苦的患者提供遠程監控用通訊設備之革命性醫療服務的電子健康 (eHealth)領域之一。行動醫療主要是利用行動及無線技術來同時監控複數疾患。由於糖尿病、肥胖症、高血壓、慢性阻塞性肺病(COPD)、閉塞性睡眠呼吸中止症(OSA)及其他文明病的增加,產生了利用先進技術,不浪費時間地預防及治療疾病之迫切需求。根據世界衛生組織(WHO)指出,2012年慢性阻塞性肺病造成的死亡人數估計310萬人,上升到全球死亡人數的約5.6%。同時該年腦中風造成的死亡人數約670萬,相當於整體的11%。目前已具備持續引進利用手機來監測心臟和呼吸、血糖值等醫療服務來定期檢查、治療疾病的機能。行動醫療的全球市場規模在2014年時相當於105億美元,預計今後到2020年前將以33.5%的年複合成長率擴大。

本報告以行動醫療的全球市場為焦點,依設備,服務,應用,相關利益者及地區 (北美,歐洲,亞太地區,中南美·中東·非洲) 別分析·預測2014-2020年這段期間交易規模的轉變,並彙整市場發展的推動·阻礙因素,產業結構,競爭環境,主要加入企業等相關的最新資訊。

第1章 簡介

  • 報告內容
  • 報告的主要優點
  • 主要市場區隔
  • 調查方法
    • 二級資訊調查
    • 主要資訊調查採訪
    • 分析工具及模式

第2章 摘要整理

  • 高階主管的觀點
  • 今後到2025年的市場預測
    • 基本預期方案
    • 急速成長方案
    • 危機的成長方案

第3章 市場概要

  • 市場定義和範圍
  • 重要發現
    • 行動醫療的全球市場最有力影響係數
    • 最有力投資口袋 - 行動醫療的全球市場
    • 最有力成功策略 - 行動醫療的全球市場
  • 波特的五力分析
  • 價值鏈分析
    • 一次活動
    • 二次活動
  • 法規問題,法規,監督機關
    • 美國的行動醫療相關法規及指令
    • 歐洲的行動醫療相關法規及指令
  • 保險·報酬方案
  • 參與企業的地位關係:2014年
  • 臨床實驗:2011-2015年
  • 專利分析:2011-2015年
    • 美國專利分析
    • 歐洲專利分析
    • 日本的專利分析
  • 市場動態
    • 推動要素
      • 伴隨手機醫療設備的無線技術的統一
      • 文明病患者的增加
      • 成本及便利性係數
      • 技術創新
      • 行政優惠措施
      • 智慧型手機的負擔能力
    • 阻礙因素
      • 開發中·初步開發地區由於缺乏認知及技術不成熟導致引進率低
      • 醫療報酬制度的不足
      • 老年人口的技術認知
      • 行政法規的不透明性限製成長
    • 機會
      • 未開拓的開發中國家市場
      • 配套服務形式所出現的商機

第4章 行動醫療的全球市場 - 設備別:2014-2020年

  • 血糖值計
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 血壓計
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 脈搏血氧計
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 神經學的監測
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 心臟監測
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 無呼吸睡眠螢幕
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 穿戴式感測器設備及心率監視器
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
  • 其他
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測

第5章 行動醫療的全球市場 - 各類服務:2014-2020年

  • 預防
    • 市場規模及預測
  • 診斷服務
    • 市場規模及預測
  • 監測服務
    • 市場規模及預測
  • 治療
    • 市場規模及預測
  • 應用/內容供給企業
    • 市場規模及預測

第6章 行動醫療的全球市場 - 相關利益者別

  • 行動通訊業者
    • 市場規模及預測
  • 設備供給企業
    • 市場規模及預測
  • 醫療提供者
    • 市場規模及預測
  • 應用/內容供給企業
    • 市場規模及預測

第7章 行動醫療的全球市場 - 各用途

  • 心血管科
    • 市場規模及預測
  • 糖尿病科
    • 市場規模及預測
  • 呼吸系統科
    • 市場規模及預測
  • 神經科
    • 市場規模及預測

第8章 行動醫療的全球市場 - 各地區

  • 北美
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
    • 法國
    • 德國
    • 英國
    • 義大利
    • 俄羅斯
    • 其他歐洲各國
  • 亞太地區
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
    • 澳洲
    • 中國
    • 日本
    • 印度
    • 其他亞太地區各國
  • 中南美,中東·非洲
    • 重要市場趨勢
    • 重要成長係數及商機
    • 市場規模及預測
    • 中南美
    • 中東
    • 非洲

第9章 企業簡介 (企業概要,企業短評,產業概要,業績,策略性動向·發展,SWOT分析等)

  • LifeWatch AG
  • Masimo Corporation
  • OMRON 醫療保健
  • Philips healthcare (a division of Royal Philips company的事業部門之一)
  • Bayer healthcare(Bayer的事業部門之一)
  • Sanofi
  • Boston Scientific Corporation
  • AT&T Inc.
  • JOHNSON & JOHNSON
目錄
Product Code: ME 15676

Mobile health (mHealth) is a branch of electronic health (eHealth) that delivers revolutionized healthcare service in which communication devices are used for the remote monitoring of patients suffering from acute and chronic diseases. mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several diseases. Rising prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD and obstructive sleep apnea (OSA) and other diseases has created an impending need of technologically advanced and less time consuming methods for prevention and treatment of these diseases. According to the World Health Organization (WHO), there were an estimated 3.1 million deaths due to COPD in 2012, which accounted for around 5.6% of all deaths worldwide. Further, nearly 6.7 million deaths occurred due to stroke in 2012, which represented around 11.9% of all deaths across the globe. The continued introduction of mobile phone based medical devices such as cardiac monitors, respiratory monitors and blood glucose monitors has addressed the need of regular monitoring and treatment of diseases in the market.

The global mHealth market was valued $10.5 billion in 2014 growing at a CAGR of 33.5% from 2015 to 2020, primarily driven by the increasing prevalence of lifestyle diseases, growing government initiatives and rising adoption of smart phones across the globe. Currently, the market is experiencing a resurgence due to the increased mobile penetration, which is more than 100% in developed markets and the similar trends in developing markets such as Asia-Pacific and Africa. Despite the mentioned benefits, low accuracy and technology infancy related to mHealth devices especially in developing and under-developed regions are the major factors limiting the growth of mHealth market.

The global mHealth market is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is further segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. BP monitors hold the dominant share in device types segment, however, blood glucose meters is estimated to be the fastest growing segment in the global mHealth devices market. This is due to the factors such as incidences of hypertension, sedentary lifestyle, increasing cases of diabetes, etc. Based on services, the market is further segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. Monitoring services occupy the dominant share in the mHealth services market and would register highest CAGR throughout the forecast period of 2015-2020. Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players. Mobile operators occupy the dominant share in the mHealth stakeholders market, whereas, the application players would register highest CAGR during the forecast period 2015-2020. Furthermore, based on applications, the mHealth market is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. Cardiovascular diseases is found to be the highest revenue generating segment, whereas diabetes is expected to register the highest CAGR during the forecast period 2015-2020. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the dominant share in the global mHealth market. Asia-Pacific is found to be the fastest growing segment.

The players profiled in this report include - Philips Healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch AG, Cardionet Inc., Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson. Product launch and collaboration are some of the key strategies adopted by the players in global mHealth market. For example, in January 2015, Masimo Corporation launched MightySat, a Fingertip Pulse Oximeter with Masimo SET Measure-through Motion and Low Perfusion Technology. Moreover, in March 2015, Omron launched smartphone connected activity tracker and fitness app.

KEY MARKET BENEFITS:

  • The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • The mHealth market scenario is comprehensively analyzed based on the key regions
  • Key market players within the mHealth market are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding the competitive outlook of the market
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
  • Comprehensive analysis of factors that drive and restrict the growth of the global mHealth market, is provided in the report
  • Exhaustive analysis of the global mHealth market by device type helps in understanding the types of devices that are currently being used along with the variants that would gain prominence in future

KEY MARKET SEGMENTS:

  • Global mHealth Market- By Devices
    • Blood glucose meters
    • BP monitors
    • Pulse oximetry
    • Neurological monitoring devices
    • Apnea and sleep monitors
    • Wearable fitness sensor device & heart rate meters
    • Others
  • Global mHealth Market- By Services
    • Diagnosis services
    • Monitoring services
    • Prevention
    • Treatment and healthcare system strengthening solutions
  • Global mHealth Market- By Stakeholders
    • Mobile operators
    • Device vendors
    • Healthcare providers
    • Application players
  • Global mHealth Market- By Application
    • Cardiovascular diseases
    • Diabetes
    • Respiratory diseases
    • Neurological diseases
    • Others
  • Global mHealth Market- By Geography
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • Australia
      • Japan
      • China
      • India
      • Rest of Asia-pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

Table of Contents

CHAPTER 1-INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2-EXECUTIVE SUMMARY

  • 2.1. CXO prospective
  • 2.2. Market beyond what expected by 2025($million)
    • 2.2.1. Base case scenario
    • 2.2.2. Rapid growth scenario
    • 2.2.3. Critical growth scenario

CHAPTER 3-MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top factors impacting global mHealth market
    • 3.2.2. Top investment pockets- global mHealth market
    • 3.2.3. Top winning strategies- global mHealth market
  • 3.3. Porters five forces analysis
    • 3.3.1. Bargaining power of buyers
    • 3.3.2. Bargaining power of suppliers
    • 3.3.3. Threat of new entrants
    • 3.3.4. Threat of substitute
    • 3.3.5. Intense competitive rivalry
  • 3.4. Value chain analysis
    • 3.4.1. Primary activities
    • 3.4.2. Secondary activities
  • 3.5. Regulatory issues, legislations and authorities
    • 3.5.1. Regulations and Directives pertaining to mHealth in the U.S.
    • 3.5.2. Regulations and directives pertaining to mHealth in EU
  • 3.6. Insurance and reimbursement scenario
  • 3.7. Market player positioning 2014
  • 3.8. Clinical trials (2011-2015)
  • 3.9. Patent analysis (2011-2015)
    • 3.9.1. US patent analysis
    • 3.9.2. Europe patent analysis
    • 3.9.3. Japan patent analysis
  • 3.10. Market dynamics
    • 3.10.1. Drivers
      • 3.10.1.1. Integration of wireless technologies with portable healthcare devices
      • 3.10.1.2. Increase in incidences of lifestyle disease
      • 3.10.1.3. Cost and Convenience Factors
      • 3.10.1.4. Technological innovations
      • 3.10.1.5. Government initiative
      • 3.10.1.6. Affordability of smartphones
    • 3.10.2. Restrains
      • 3.10.2.1. Lower adoption due to lack of awareness and technology infancy in developing and under developed region
      • 3.10.2.2. Weak reimbursement coverage
      • 3.10.2.3. Technological awareness among the ageing population
      • 3.10.2.4. Uncertainty in the government regulations is expected to hinder the growth rate
    • 3.10.3. Opportunities
      • 3.10.3.1. Untapped market of developing economies
      • 3.10.3.2. Rising Opportunities in the form of bundled services

CHAPTER 4-GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020

  • 4.1. Blood glucose meter
    • 4.1.1. Key market trends
    • 4.1.2. Growth factors and opportunity
    • 4.1.3. Market size and forecast
  • 4.2. BP monitors
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunity
    • 4.2.3. Market size and forecast
  • 4.3. Pulse oximetry
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and Opportunity
    • 4.3.3. Market size and forecast
  • 4.4. Neurological monitoring
    • 4.4.1. Key market trends
    • 4.4.2. Growth factors and Opportunity
    • 4.4.3. Market size and forecast
  • 4.5. Cardiac monitors
    • 4.5.1. Key market trends
    • 4.5.2. Growth factors and Opportunity
    • 4.5.3. Market size and forecast
  • 4.6. Apnea and sleep monitors
    • 4.6.1. Key market trends
    • 4.6.2. Growth factors and Opportunity
    • 4.6.3. Market size and forecast
  • 4.7. Wearable fitness sensor device and Heart Rate Meters
    • 4.7.1. Key market trends
    • 4.7.2. Growth factors and Opportunity
    • 4.7.3. Market size and forecast
  • 4.8. Others
    • 4.8.1. Key market trends
    • 4.8.2. Growth factors and opportunity
    • 4.8.3. Market size and forecast

CHAPTER 5-GLOBAL MHEALTH MARKET, BY SERVICES, 2014-2020

  • 5.1. Prevention
    • 5.1.1. Market size and forecast
  • 5.2. Diagnostic services
    • 5.2.1. Market size and forecast
    • 5.3. Monitoring services
    • 5.3.1. Market size and forecast
  • 5.4. Treatment
    • 5.4.1. Market size and forecast
  • 5.5. Wellness and healthcare system strengthening solutions
    • 5.5.1. Market size and forecast

CHAPTER 6-GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2014-2020

  • 6.1. Mobile operators
    • 6.1.1. Market size and forecast
  • 6.2. Device vendors
    • 6.2.1. Market size and forecast
  • 6.3. Healthcare Providers
    • 6.3.1. Market size and forecast
  • 6.4. Application/ Content Players
    • 6.4.1. Market size and forecast

CHAPTER 7-GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2020

  • 7.1. Cardiovascular
    • 7.1.1. Market size and forecast
  • 7.2. Diabetes
    • 7.2.1. Market size and forecast
  • 7.3. Respiratory
    • 7.3.1. Market size and forecast
  • 7.4. Neurology
    • 7.4.1. Market size and forecast

CHAPTER 8-GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2020

  • 8.1. North America
    • 8.1.1. Key market trends
    • 8.1.2. Key growth factors and opportunity
    • 8.1.3. Market size and forecast
    • 8.1.4. United States
      • 8.1.4.1. Market size and forecast
    • 8.1.5. Canada
      • 8.1.5.1. Market size and forecast
    • 8.1.6. Mexico
      • 8.1.6.1. Market size and forecast
  • 8.2. Europe
    • 8.2.1. Key market trends
    • 8.2.2. Key growth factors and opportunity
    • 8.2.3. Market size and forecast
    • 8.2.4. France
      • 8.2.4.1. Market size and forecast
    • 8.2.5. Germany
      • 8.2.5.1. Market size and forecast
    • 8.2.6. United Kingdom
      • 8.2.6.1. Market size and forecast
    • 8.2.7. Italy
      • 8.2.7.1. Market size and forecast
    • 8.2.8. Russia
      • 8.2.8.1. Market size and forecast
    • 8.2.9. Rest of Europe
      • 8.2.9.1. Market size and forecast
  • 8.3. Asia-Pacific
    • 8.3.1. Key market trends
    • 8.3.2. Key growth factors and opportunity
    • 8.3.3. Market size and forecast
    • 8.3.4. Australia
      • 8.3.4.1. Market size and forecast
    • 8.3.5. China
      • 8.3.5.1. Market size and forecast
    • 8.3.6. Japan
      • 8.3.6.1. Market size and forecast
    • 8.3.7. India
      • 8.3.7.1. Market size and forecast
    • 8.3.8. Rest of Asia-pacific
      • 8.3.8.1. Market size and forecast
  • 8.4. LAMEA
    • 8.4.1. Key market trends
    • 8.4.2. Key growth factors and opportunity
    • 8.4.3. Market size and forecast
    • 8.4.4. Latin America
      • 8.4.4.1. Market size and forecast
    • 8.4.5. Middle East
      • 8.4.5.1. Market size and forecast
    • 8.4.6. Africa
      • 8.4.6.1. Market size and forecast

CHAPTER 9-COMPANY PROFILES

  • 9.1. LifeWatch AG
    • 9.1.1. Company overview
    • 9.1.2. LifeWatch AG snapshot
    • 9.1.3. Operating business segment overview
    • 9.1.4. Business performance
    • 9.1.5. Strategic moves and development
    • 9.1.6. SWOT analysis of LifeWatch AG
  • 9.2. Masimo Corporation
    • 9.2.1. Company overview
    • 9.2.2. Masimo Corporation snapshot
    • 9.2.3. Operating business segment overview
    • 9.2.4. Business performance
    • 9.2.5. Strategic moves and developments
    • 9.2.6. SWOT analysis of Masimo Corporation
  • 9.3. Omron healthcare
    • 9.3.1. Company overview
    • 9.3.2. Omron Healthcare snapshot
    • 9.3.3. Operating business segment overview
    • 9.3.4. Business performance
    • 9.3.5. Strategic moves and developments
    • 9.3.6. SWOT analysis of Omron Healthcare Inc.
  • 9.4. Philips healthcare (a division of Royal Philips company)
    • 9.4.1. Company overview
    • 9.4.2. Philips Healthcare snapshot
    • 9.4.3. Operating business segment overview
    • 9.4.4. Business performance
    • 9.4.5. Strategic moves and developments
    • 9.4.6. SWOT analysis of Philips Healthcare
  • 9.5. Bayer healthcare (a division of Bayer)
    • 9.5.1. Company overview
    • 9.5.2. Bayer Healthcare snapshot
    • 9.5.3. Operating Business Segment overview
    • 9.5.4. Business performance
    • 9.5.5. Strategic moves and development
    • 9.5.6. SWOT Analysis Of Bayer Healthcare
  • 9.6. Sanofi
    • 9.6.1. Company overview
    • 9.6.2. Sanofi snapshot
    • 9.6.3. Operating business segment overview
    • 9.6.4. Business performance
    • 9.6.5. Strategic moves and developments
    • 9.6.6. SWOT analysis of Sanofi
  • 9.7. Boston Scientific Corporation
    • 9.7.1. Company overview
    • 9.7.2. Boston Scientific Corporation snapshot
    • 9.7.3. Operating business segment
    • 9.7.4. Business performance
    • 9.7.5. Strategic moves and developments
    • 9.7.6. SWOT analysis of Boston Scientific Corporation
  • 9.8. AT&T Inc.
    • 9.8.1. Company overview
    • 9.8.2. AT&T Inc. snapshot
    • 9.8.3. Operating business segment
    • 9.8.4. Business performance
    • 9.8.5. Strategic moves and developments
    • 9.8.6. SWOT analysis of AT&T Inc.
  • 9.9. JOHNSON & JOHNSON
    • 9.9.1. Company overview
    • 9.9.2. Johnson & Johnson Inc. snapshot
    • 9.9.3. Operating business segment overview
    • 9.9.4. Business performance
    • 9.9.5. Strategic moves and developments
    • 9.9.6. SWOT analysis of Johnson & Johnson Inc.

List of Tables

  • TABLE 1: GLOBAL MHEALTH MARKET BY GEOGRAPHY, MODERATE GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 2: GLOBAL MHEALTH MARKET BY GEOGRAPHY, RAPID GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 3: GLOBAL MHEALTH MARKET BY GEOGRAPHY, CRITICAL GROWTH SCENARIO, 2020 - 2025, ($MILLION)
  • TABLE 4: CLINICAL TRIALS 2011-2015
  • TABLE 5: PATENT ANALYSIS- UNITED STATES (2011-2014)
  • TABLE 6: PATENT ANALYSIS- EUROPE (2011-2014)
  • TABLE 7: PATENT ANALYSIS- JAPAN (2011-2014)
  • TABLE 8: GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
  • TABLE 9: DIABETES RELATED SMART PHONE APPLICATIONS
  • TABLE 10: GLOBAL MHEALTH BLOOD GLUCOSE METERS MARKET, BY GEOGRAPHY, 2014 - 2020($MILLION)
  • TABLE 11: MOBILE COMPATIBLE BP MONITORS
  • TABLE 12: GLOBAL MHEALTH BP MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 13: AVAILABLE PULSE OXIMETERS AND ITS COST
  • TABLE 14: GLOBAL MHEALTH PULSE OXIMETERY MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 15: GLOBAL MHEALTH NEUROLOGICAL MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 16: GLOBAL MHEALTH CARDIAC MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 17: SLEEP AND APNEA DEVICES
  • TABLE 18: GLOBAL MHEALTH APNEA & SLEEP MONITORS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 19: WEARABLE FITNESS DEVICES AND ITS COST
  • TABLE 20: GLOBAL MHEALTH WEARABLE FITNESS SENSOR DEVICES AND HEART RATE METERS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 21: GLOBAL MHEALTH OTHER DEVICES MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 22: GLOBAL M-HEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
  • TABLE 23: GLOBAL M-HEALTH SERVICES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 24: SMARTPHONE APPS FOR PREVENTIVE SERVICES
  • TABLE 25: MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
  • TABLE 26: GLOBAL MHEALTH PREVENTION SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 27: GLOBAL MHEALTH DIAGNOSIS SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 28: GLOBAL MHEALTH MONITORING SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 29: GLOBAL MHEALTH TREATMENT SERVICE MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 30: GLOBAL MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY GEOGRAPHY, 2014 - 2020 ($MILLION)
  • TABLE 31: GLOBAL MHEALTH MARKET, BY STAKEHOLDERS,2014 - 2020 ($MILLION)
  • TABLE 32: GLOBAL MHEALTH STAKEHOLDERS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
  • TABLE 33: GLOBAL MHEALTH MOBILE OPERATORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 34: GLOBAL MHEALTH DEVICE VENDORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 35: GLOBAL MHEALTH HEALTHCARE PROVIDERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 36: GLOBAL MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 37: GLOBAL MHEALTH MARKET BY APPLICATION, 2014 - 2020 ($MILLION)
  • TABLE 38: GLOBAL MHEALTH APPLICATION MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 39: GLOBAL MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 40: PREVALENCE AND PROJECTIONS (DIABETES)
  • TABLE 41: GLOBAL MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 42: GLOBAL MHEALTH RESPIRATORY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 43: GLOBAL NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
  • TABLE 44: GLOBAL MHEALTH NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
  • TABLE 45: IMPACT ANALYSIS PENETRATING TO GEOGRAPHY 2014
  • TABLE 46: NORTH AMERICA MHEALTH DEVICES MARKET BY COUNTRY, 2014 - 2020 ($MILLION)
  • TABLE 47: UNITED STATES MHEALTH MARKET (DEVICES AND SERVICES), 2014-2020, ($MILLION)
  • TABLE 48: CANADA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 49: EUROPE MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 50: EUROPE MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 51: FRANCE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 52: GERMANY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 53: UNITED KINGDOM (DEVICES AND SERVICES) MHEALTH MARKET, 2014-2020, ($MILLION)
  • TABLE 54: ITALY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 55: RUSSIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 56: REST OF EUROPE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 57: ASIA-PACIFIC MHEALTH DEVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
  • TABLE 58: ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
  • TABLE 59: AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 60: CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 61: JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 62: INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
  • TABLE 63: REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 64: LAMEA MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 65: LAMEA MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
  • TABLE 66: LATIN AMERICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 67: MIDDLE EAST MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 68: AFRICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
  • TABLE 69: LIFEWATCH AG COMPANY SNAPSHOT
  • TABLE 70: MASIMO CORPORATION SNAPSHOT
  • TABLE 71: OPERATING SEGMENT
  • TABLE 72: OMRON HEALTHCARE SNAPSHOT
  • TABLE 73: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 74: PHILIPS HEALTHCARE SNAPSHOT
  • TABLE 75: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 76: BAYER HEALTHCARE SNAPSHOT
  • TABLE 77: OPERATING BUSINESS SEGMENT OVERVIEW
  • TABLE 78: SANOFI SNAPSHOT OF SANOFI
  • TABLE 79: OPERATING BUSINESS SEGMENTS OVERVIEW
  • TABLE 80: BOSTON SCIENTIFIC CORPORATION SNAPSHOT
  • TABLE 81: OPERATING BUSINESS SEGMENT
  • TABLE 82: AT&T INC. SNAPSHOT
  • TABLE 83: OPERATING BUSIMESS SEGMENT
  • TABLE 84: JOHNSON & JOHNSON INC. COMPANY SNAPSHOT
  • TABLE 85: OPERATING BUSINESS

List of Figures

  • FIG. 1: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN MODERATE GROWTH SCENARIO
  • FIG. 2: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN RAPID GROWTH SCENARIO
  • FIG. 3: IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN CRITICAL GROWTH SCENARIO
  • FIG. 4: TOP IMPACTING FACTORS OF GLOBAL MHEALTH MARKET 2014-2020
  • FIG. 5: TOP INVESTMENT POCKETS
  • FIG. 6: TOP WINNING STRATEGIES
  • FIG. 7: PORTER'S FIVE FORCES ANALYSIS
  • FIG. 8: VALUE CHAIN ANALYSIS OF GLOBAL MHEALTH MARKET
  • FIG. 9: MARKET PLAYER POSITIONING 2014
  • FIG. 10: PATENT ANALYSIS, BY GEOGRAPHY, 2011-2015
  • FIG. 11: US PATENT ANALYSIS
  • FIG. 12: EUROPE PATENT ANALYSIS
  • FIG. 13: JAPAN PATENT ANALYSIS
  • FIG. 14: GLOBAL PER CAPITA SMARTPHONE PENETRATION (2011-2018)
  • FIG. 15: ESTIMATED DEATH DUE TO CVDS (MILLION)
  • FIG. 16: PENETRATION OF SMARTPHONE USERS BY APPLICATIONS
  • FIG. 17: MHEALTH INITIATIVE BY WORLD HEALTH ORGANIZATION
  • FIG. 18: SMARTPHONE OWNERSHIP IN UNITED STATES (2011-2014)
  • FIG. 19: HEART RATE MONITORS
  • FIG. 20: DEATHS DUE TO CVD
  • FIG. 21: ASTHMA PREVALENCE IN UNITED STATES IN 2011
  • FIG. 22: CANADIAN'S OPINION ABOUT HEALTHCARE SYSTEM
  • FIG. 23: BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
  • FIG. 24: REVENUE BY BUSINESS SEGMENT (2014)
  • FIG. 25: REVENUE BY REGION (2014)
  • FIG. 26: SWOT ANALYSIS OF LIFEWATCH AG
  • FIG. 27: BUSINESS PERFORMANCE OF MASIMO 2012-2014 ($MILLION)
  • FIG. 28: SWOT ANALYSIS OF MASIMO CORPORATION
  • FIG. 29: NET SALES OF OMRON ($MILLION)
  • FIG. 30: OMRON'S NET SALES BY OPERATING SEGMENT (2013)
  • FIG. 31: OMRON'S NET SALES BY REGION (2013)
  • FIG. 32: SWOT ANALYSIS OF OMRON HEALTHCARE INC.
  • FIG. 33: PHILIPS NET SALES 2012-2014 ($MILLION)
  • FIG. 34: PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
  • FIG. 35: SWOT ANALYSIS OF PHILIPS HEALTHCARE
  • FIG. 36: NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
  • FIG. 37: BAYER HEALTHCARE'S REVENUE BY OPERATING SEGMENT IN 2014
  • FIG. 38: SWOT ANALYSIS OF BAYER HEALTHCARE
  • FIG. 39: NET SALES OF SANOFI 2012-2014 ($MILLION)
  • FIG. 40: NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
  • FIG. 41: NET SALES OF SANOFI BY GEOGRAPHY 2014
  • FIG. 42: SWOT ANALYSIS OF SANOFI
  • FIG. 43: OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
  • FIG. 44: OPERATIONAL SALES BY OPERATING SEGMENT 2014
  • FIG. 45: SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
  • FIG. 46: REVENUE OF AT&T INC. 2012-2014 ($MILLION)
  • FIG. 47: SWOT ANALYSIS OF AT&T INC.
  • FIG. 48: NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
  • FIG. 49: NET SALES BY OPERATING SEGMENT 2014
  • FIG. 50: SWOT ANALYSIS OF JOHNSON & JOHNSON INC.
Back to Top